Key Financial Data Of Reporting Company

KYORIN Pharmaceutical Co., Ltd. - Filing #7351594

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
87,267,000,000 JPY
113,270,000,000 JPY
80,707,000,000 JPY
Ordinary profit (loss)
5,053,000,000 JPY
5,827,000,000 JPY
5,336,000,000 JPY
Net assets
126,576,000,000 JPY
125,461,000,000 JPY
126,788,000,000 JPY
Total assets
178,942,000,000 JPY
176,045,000,000 JPY
174,562,000,000 JPY
Basic earnings (loss) per share
68.23
37.55
82.44
76.40
54.71
Diluted earnings per share
Equity-to-asset ratio
0.707 xbrli:pure
0.713 xbrli:pure
0.726 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.